Products

What will AGI do for Betahistine?

This classification denotes a vasodilating agent with the molecular formula C8H12N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X32KK4201D, chemically known as 2-pyridineethanamine, n-methyl- but generally known as betahistine, which bears US NIH Compound Identifier 2366. Betahistine most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. European Medicines Agency schedules Betahistine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05794MIG. The term BETAHISTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules betahistine in its Anatomical Therapeutic Chemical (ATC) Classification. BETAHISTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule betahistine under HS 29333999 and SITC 51574. As of Q4 2014, BETAHISTINE remains the US FDA Preferred Term for this commodity. Betahistine bears US NLM identifiers UMLS ID C0005301 and NCI Concept Code C83554. SMILES: N(CCC1NCCCC1)C.